Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biomedical Analysis is Scopus-indexed (Q3, CiteScore 3), DOAJ. Published by KeAi Communications Co..
Checked against the index lists dated .
ISSN 2950-435XVerify ISSN ↗
Publisher: KeAi Communications Co.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biomedical Engineering | 215 / 342 | 37th | Q3 |
| Analytical Chemistry | 111 / 160 | 30th | Q3 |
| Biochemistry | 316 / 448 | 29th | Q3 |
| Cancer Research | 177 / 233 | 24th | Q4 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2024–present, best quartile Q3, CiteScore 3.
Biomedical Analysis is Q3 in Biomedical Engineering (rank 215 of 342), Q3 in Analytical Chemistry (rank 111 of 160) and Q3 in Biochemistry (rank 316 of 448), by CiteScore 2025. It is ranked in 4 subject areas in all.
Biomedical Analysis is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 3, quartile Q3, 37th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.574, quartile Q2, with an H-index of 7.
No article processing charge is recorded for it (source: OpenAlex). Confirm on the journal's own website, since some journals charge for extras such as colour figures.
Biomedical Analysis is published by KeAi Communications Co. Its ISSN is 2950-435X.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Biomedical Analysis has an h-index of 13 and a 2-year mean of 5.61 citations per paper (OpenAlex). Its Scopus CiteScore is 3, quartile Q3. On 2-year citations it ranks #66 of 322 Scopus journals in Biomedical Engineering.
Biomedical Analysis published 21 papers in 2025; its busiest recent year was 2024 with 24. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 51 research articles (2024–2026), authors are most often from China (64.9%), India (18.6%) and United States (4.4%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.